Get Your Personalized Supplement StackSupplement Stack Quiz

Guanidino Propionic Acid

Q: Is β-GPA safe for long-term use?

The long-term safety of β-GPA in humans is not well understood, so consulting a healthcare provider is recommended before starting.

Q: How should I take β-GPA?

There are no established guidelines for timing and administration, so personal consultation with a healthcare provider is advisable.

Q: What effects should I expect from β-GPA?

Animal studies suggest possible reductions in blood pressure and improved glucose metabolism, but these need confirmation in human trials.

Q: Is β-GPA a natural compound?

No, β-GPA is a synthetic compound and is not naturally occurring.

Q: Can I take β-GPA with other supplements or medications?

While specific drug interactions are not detailed, caution is advised when combining with other substances that affect energy metabolism.

Also known as: β-GPA, Guanidino Propionic Acid, Beta-GPA, Beta-Guanidinopropionic Acid

Overview

Beta-Guanidinopropionic acid (β-GPA) is a synthetic derivative of creatine primarily utilized as a dietary supplement for its potential cardiovascular and metabolic benefits. Characterized as a white crystalline powder, β-GPA is soluble in water, facilitating its oral ingestion. Initial studies suggest that β-GPA may inhibit the enzyme creatine kinase, which is critical for ATP production and energy distribution within the body. Preclinical data from animal studies indicate that β-GPA has the potential to lower blood pressure and enhance glucose metabolism, particularly in hypertensive and noninsulin-dependent diabetic models. However, most findings are from preclinical research, emphasizing the need for further human studies to confirm these effects and explore specific clinical applications.

Benefits

The primary benefit identified for β-GPA is its significant capacity to lower blood pressure, as evidenced in studies involving spontaneously hypertensive rats, which recorded average reductions of 42.7 mm Hg for systolic and 35.3 mm Hg for diastolic blood pressure, with high statistical significance (p < 0.001). Additionally, β-GPA has been linked to improved vasodilatory responses and enhanced glucose metabolism, particularly studied in models reflecting noninsulin-dependent diabetes. While these findings are promising, the implications for human health are not yet clear, highlighting the necessity for comprehensive large-scale clinical trials to further explore β-GPA's effectiveness across various health conditions.

How it works

β-GPA exerts its effects primarily by inhibiting the enzyme creatine kinase, essential for ATP production and energy metabolism. This inhibition reduces energy availability, which is necessary for vascular contraction and sodium retention, resulting in lowered blood pressure and improved vasodilation. Furthermore, β-GPA may influence pathways related to glucose metabolism, suggesting potential benefits for individuals with diabetes, as indicated by several animal studies.

Side effects

The long-term safety profile of β-GPA is largely undetermined in human populations due to a lack of extensive research. Animal studies suggest that β-GPA is generally well-tolerated, showing no significant adverse effects reported. However, there are no documented common side effects in humans, and potential drug interactions remain unclear. Individuals with existing cardiovascular or metabolic conditions should consult a healthcare provider prior to use. Additionally, pregnant and breastfeeding women are advised to avoid β-GPA due to insufficient safety data, accentuating the need for further studies to evaluate the safety of β-GPA during these conditions.

Dosage

Presently, there is no established dosage for human use of β-GPA; findings from animal studies may not directly apply to humans. Safe maximum dosage limits have not yet been defined, indicating a critical requirement for focused research to ascertain effective dosing recommendations. Absence of specific timing and administration guidelines also underscores the importance of seeking healthcare professional advice for personalized dosage recommendations. Being water-soluble, β-GPA is suitable for oral intake; however, further investigations are needed to define its formulations and absorption characteristics.